Abstract
Diabetes mellitus (DM) continues to impact a considerable section of the population. Insulin (IN) is required on a daily basis by the majority of people infected. Diabetes had a huge impact on patients' life prior to the introduction of the first produced IN in 1978. Significant progress has been made in the management of DM as technology and human inventiveness have prevailed. Now, patients have the choice of choosing their INdelivery mode, and they are easier to administer. The current review focuses on the traditional IN therapy and evolution of IN analogues (IN like substances). Various routes of administrations of IN such as oral, transdermal, intranasalare also discussed. The recent novel drug delivery systems explored for the delivery of IN along with the continuous glucose monitoring systems (CGM) for DM management are also highlighted.
| Original language | English |
|---|---|
| Article number | 103728 |
| Journal | Journal of Drug Delivery Science and Technology |
| Volume | 75 |
| DOIs | |
| State | Published - Sep 2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Diabetes mellitus
- Electroporation
- Insulin
- Insulin analogues
- Intranasal delivery
- Iontophoresis
- NDDS
- Transdermal delivery
- Wearable technology
Fingerprint
Dive into the research topics of 'An overview of recent advances in insulin delivery and wearable technology for effective management of diabetes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver